Bladder Preservation by Neoadjuvant Chemotherapy followed by Concurrent Chemoradiotherapy with Gemcitabine in Muscle Invasive Bladder Cancer (MIBC)

被引：0
|
作者：
Anandadas, C. [1 ]
Thompson, C. [1 ]
Sanderson, B. [1 ]
Lyons, J. [1 ]
Stratford, J. [1 ]
Logue, J. P. [1 ]
机构：
[1] Christie NHS Fdn Trust, Manchester, Lancs, England
来源：
CLINICAL ONCOLOGY | 2013年 / 25卷 / 04期
关键词：
D O I：
10.1016/j.clon.2012.12.009
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E69 / E69
页数：1
相关论文
共 50 条
  • [21] Neoadjuvant chemotherapy in muscle invasive bladder cancer
    Suer, Evren
    Turkolmez, Kadir
    [J]. UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2012, 11 (01): : 74 - 78
  • [22] Tolerability of Concurrent Chemoradiation Therapy With Gemcitabine (GemX), With and Without Prior Neoadjuvant Chemotherapy, in Muscle Invasive Bladder Cancer
    Thompson, Catherine
    Joseph, Nuradh
    Sanderson, Benjamin
    Logue, John
    Wylie, James
    Elliott, Tony
    Lyons, Jeanette
    Anandadas, Carmel
    Choudhury, Ananya
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 97 (04): : 732 - 739
  • [23] Optimal timing of radical cystectomy after neoadjuvant chemotherapy in muscle invasive bladder cancer (MIBC)
    Parasramka, Saurabh
    Veedu, Janeesh Sekkath
    Chen, Quan
    Huang, Bin
    Wang, Peng
    Myint, Zin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [24] Outcomes of Organ Preservation Chemoradiotherapy for Muscle-Invasive Bladder Cancer (MIBC) - Single Centre Experience
    Wong, Emily Hui Ming
    Ibrahim, Aisyah Haji
    Salih, Osama Sayed M.
    Huang, Roger
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 52 - 52
  • [25] A phase II study of neoadjuvant chemotherapy followed by organ preservation in patients with muscle-invasive bladder cancer
    Dracham, Chinna Babu
    Kumar, Narendra
    Kumar, Santosh
    Elangovan, Arun
    Yadav, Budhi Singh
    Mavuduru, Ravimohan S.
    Lal, Anupam
    Gupta, Pramod K.
    Kapoor, Rakesh
    [J]. ASIAN JOURNAL OF UROLOGY, 2022, 9 (03) : 318 - 328
  • [26] Bladder preservation strategy with induction chemotherapy (CT) followed by chemoradiotherapy (CRT) in bladder cancer
    Ozkan, A.
    Mayadagli, A.
    Kocak, M.
    Demir, O.
    Parlak, C.
    Gul, S. K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [27] Bladder Preservation Using Neoadjuvant Chemotherapy and Continuous Definitive Chemoradiation Therapy for Muscle Invasive Bladder Cancer
    Lopez-Araujo, J.
    Baden, C. J.
    Fiveash, J. B.
    Dobelbower, C. M.
    Bolger, G. B.
    Jacob, R.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S400 - S400
  • [28] Tolerability of Concurrent Chemoradiotherapy with Gemcitabine (GemX), With and Without Prior Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer: Physician- and Patient-reported Outcomes
    Thompson, C.
    Sanderson, B.
    Liptrot, T.
    Wylie, J.
    Choudhury, A.
    Logue, J.
    [J]. CLINICAL ONCOLOGY, 2015, 27 (03) : E6 - E6
  • [29] Feasibility and efficacy of gemcitabine and carboplatin neoadjuvant chemotherapy in muscle-invasive bladder cancer
    Koie, T.
    Yamamoto, H.
    Okamoto, A.
    Hatakeyama, S.
    Momose, A.
    Iwabuchi, I.
    Yoneyama, T.
    Hashimoto, Y.
    Kamimura, N.
    Ohyama, C.
    Saijo, Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [30] Neoadjuvant Chemotherapy Before Bladder-Sparing Chemoradiotherapy in Patients With Nonmetastatic Muscle-Invasive Bladder Cancer
    Jiang, Di
    Jiang, Haiyan
    Chung, Peter W. M.
    Zlotta, Alexandre R.
    Fleshner, Neil Eric
    Bristow, Robert G.
    Berlin, Alejandro
    Kulkarni, Girish S.
    Alimohamed, Nimira S.
    Lo, Gregory
    Sridhar, Srikala S.
    [J]. CLINICAL GENITOURINARY CANCER, 2019, 17 (01) : 38 - 45
12345